JENNIFER SIZEMORE: Open Payments
NPI 1083706774 · LONDON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$985 in 59 payments from 10 companies in 2025. Trend: 2023 $1,154 · 2024 $1,037 · 2025 $985
Food & beverage: $985
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $252 |
| PFIZER INC. | 15 | $239 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 14 | $137 |
| E.R. Squibb & Sons, L.L.C. | 5 | $76 |
| Merck Sharp & Dohme LLC | 4 | $74 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $51 |
| Boston Scientific Corporation | 3 | $51 |
| Kestra Medical Technology Services, Inc. | 2 | $50 |
| Edwards Lifesciences Corporation | 1 | $33 |
| Novo Nordisk Inc | 1 | $23 |
Products named: ELIQUIS, LEQVIO, LifeVest, VYNDAQEL, VERQUVO, Kerendia, Assure WCD, Edwards SAPIEN 3 Ultra Transcatheter Heart Valve.
Industry payments across KY — which companies pay providers there.
